Annual CFO
-$33.04 M
+$13.97 M+29.72%
December 31, 2023
Summary
- As of February 12, 2025, PLSE annual cash flow from operations is -$33.04 million, with the most recent change of +$13.97 million (+29.72%) on December 31, 2023.
- During the last 3 years, PLSE annual CFO has risen by +$2.32 million (+6.57%).
- PLSE annual CFO is now -896.11% below its all-time high of -$3.32 million, reached on December 31, 2015.
Performance
PLSE Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$9.02 M
-$629.00 K-7.49%
September 30, 2024
Summary
- As of February 12, 2025, PLSE quarterly cash flow from operations is -$9.02 million, with the most recent change of -$629.00 thousand (-7.49%) on September 30, 2024.
- Over the past year, PLSE quarterly CFO has increased by +$756.00 thousand (+7.73%).
- PLSE quarterly CFO is now -1874.62% below its all-time high of -$457.00 thousand, reached on March 31, 2015.
Performance
PLSE Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$33.98 M
+$1.46 M+4.13%
September 30, 2024
Summary
- As of February 12, 2025, PLSE TTM cash flow from operations is -$33.98 million, with the most recent change of +$1.46 million (+4.13%) on September 30, 2024.
- Over the past year, PLSE TTM CFO has increased by +$2.27 million (+6.26%).
- PLSE TTM CFO is now -7335.67% below its all-time high of -$457.00 thousand, reached on March 31, 2015.
Performance
PLSE TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
PLSE Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +29.7% | +7.7% | +6.3% |
| 3 y3 years | +6.6% | +28.9% | +37.2% |
| 5 y5 years | -38.3% | +44.9% | +25.9% |
PLSE Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +38.9% | -37.4% | +42.1% | -2.8% | +41.4% |
| 5 y | 5-year | at high | +38.9% | -37.4% | +44.9% | -2.8% | +41.4% |
| alltime | all time | -896.1% | +38.9% | -1874.6% | +44.9% | -7335.7% | +41.4% |
Pulse Biosciences Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$9.02 M(+7.5%) | -$33.98 M(-4.1%) |
| Jun 2024 | - | -$8.39 M(-14.2%) | -$35.44 M(-2.2%) |
| Mar 2024 | - | -$9.78 M(+44.2%) | -$36.25 M(+9.7%) |
| Dec 2023 | -$33.04 M(-29.7%) | -$6.78 M(-35.3%) | -$33.04 M(-3.5%) |
| Sep 2023 | - | -$10.49 M(+14.0%) | -$34.22 M(-0.4%) |
| Jun 2023 | - | -$9.20 M(+40.1%) | -$34.37 M(-9.5%) |
| Mar 2023 | - | -$6.57 M(-17.5%) | -$37.99 M(-19.2%) |
| Dec 2022 | -$47.01 M(-13.1%) | -$7.96 M(-25.1%) | -$47.01 M(-9.1%) |
| Sep 2022 | - | -$10.63 M(-17.1%) | -$51.74 M(-5.0%) |
| Jun 2022 | - | -$12.82 M(-17.8%) | -$54.46 M(-6.1%) |
| Mar 2022 | - | -$15.59 M(+22.8%) | -$58.00 M(+7.2%) |
| Dec 2021 | -$54.10 M(+53.0%) | -$12.69 M(-4.9%) | -$54.10 M(+6.8%) |
| Sep 2021 | - | -$13.35 M(-18.4%) | -$50.66 M(+10.5%) |
| Jun 2021 | - | -$16.37 M(+40.0%) | -$45.86 M(+22.5%) |
| Mar 2021 | - | -$11.69 M(+26.3%) | -$37.43 M(+5.8%) |
| Dec 2020 | -$35.37 M(+3.5%) | -$9.26 M(+8.3%) | -$35.37 M(+0.2%) |
| Sep 2020 | - | -$8.55 M(+7.7%) | -$35.31 M(+1.7%) |
| Jun 2020 | - | -$7.94 M(-17.5%) | -$34.72 M(-4.8%) |
| Mar 2020 | - | -$9.62 M(+4.6%) | -$36.48 M(+6.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | -$34.19 M(+43.1%) | -$9.20 M(+15.5%) | -$34.19 M(+9.2%) |
| Sep 2019 | - | -$7.96 M(-17.8%) | -$31.30 M(+3.7%) |
| Jun 2019 | - | -$9.69 M(+32.3%) | -$30.18 M(+15.2%) |
| Mar 2019 | - | -$7.33 M(+16.2%) | -$26.21 M(+9.7%) |
| Dec 2018 | -$23.90 M(+115.5%) | -$6.31 M(-7.9%) | -$23.90 M(+10.9%) |
| Sep 2018 | - | -$6.85 M(+19.8%) | -$21.55 M(+18.9%) |
| Jun 2018 | - | -$5.72 M(+14.0%) | -$18.12 M(+33.2%) |
| Mar 2018 | - | -$5.02 M(+26.6%) | -$13.61 M(+22.7%) |
| Dec 2017 | -$11.09 M(+37.7%) | -$3.96 M(+16.0%) | -$11.09 M(+17.4%) |
| Sep 2017 | - | -$3.42 M(+182.9%) | -$9.44 M(+17.9%) |
| Jun 2017 | - | -$1.21 M(-51.7%) | -$8.01 M(-11.9%) |
| Mar 2017 | - | -$2.50 M(+7.8%) | -$9.09 M(+12.9%) |
| Dec 2016 | -$8.05 M(+142.7%) | -$2.32 M(+17.0%) | -$8.05 M(+14.0%) |
| Sep 2016 | - | -$1.98 M(-13.4%) | -$7.06 M(+17.2%) |
| Jun 2016 | - | -$2.29 M(+56.6%) | -$6.03 M(+39.5%) |
| Mar 2016 | - | -$1.46 M(+9.9%) | -$4.32 M(+30.3%) |
| Dec 2015 | -$3.32 M | -$1.33 M(+40.3%) | -$3.32 M(+66.9%) |
| Sep 2015 | - | -$948.00 K(+62.9%) | -$1.99 M(+91.2%) |
| Jun 2015 | - | -$582.00 K(+27.4%) | -$1.04 M(+127.4%) |
| Mar 2015 | - | -$457.00 K | -$457.00 K |
FAQ
- What is Pulse Biosciences annual cash flow from operations?
- What is the all time high annual CFO for Pulse Biosciences?
- What is Pulse Biosciences annual CFO year-on-year change?
- What is Pulse Biosciences quarterly cash flow from operations?
- What is the all time high quarterly CFO for Pulse Biosciences?
- What is Pulse Biosciences quarterly CFO year-on-year change?
- What is Pulse Biosciences TTM cash flow from operations?
- What is the all time high TTM CFO for Pulse Biosciences?
- What is Pulse Biosciences TTM CFO year-on-year change?
What is Pulse Biosciences annual cash flow from operations?
The current annual CFO of PLSE is -$33.04 M
What is the all time high annual CFO for Pulse Biosciences?
Pulse Biosciences all-time high annual cash flow from operations is -$3.32 M
What is Pulse Biosciences annual CFO year-on-year change?
Over the past year, PLSE annual cash flow from operations has changed by +$13.97 M (+29.72%)
What is Pulse Biosciences quarterly cash flow from operations?
The current quarterly CFO of PLSE is -$9.02 M
What is the all time high quarterly CFO for Pulse Biosciences?
Pulse Biosciences all-time high quarterly cash flow from operations is -$457.00 K
What is Pulse Biosciences quarterly CFO year-on-year change?
Over the past year, PLSE quarterly cash flow from operations has changed by +$756.00 K (+7.73%)
What is Pulse Biosciences TTM cash flow from operations?
The current TTM CFO of PLSE is -$33.98 M
What is the all time high TTM CFO for Pulse Biosciences?
Pulse Biosciences all-time high TTM cash flow from operations is -$457.00 K
What is Pulse Biosciences TTM CFO year-on-year change?
Over the past year, PLSE TTM cash flow from operations has changed by +$2.27 M (+6.26%)